Cerenome Reports Q3 Revenue of $0.7 Million and $8.7 Million Net Loss

Cerenome reported third-quarter 2026 revenue of $0.7 million, all from diagnostics, and a net loss of $8.7 million. Operating loss was $7.5 million, while cash, cash equivalents and investments totaled $4.9 million at September 30. The company also reported progress in CNSide commercialization and…